
|Videos|July 16, 2020
Glaucoma 360: Pharmaceuticals in the glaucoma industry
Author(s)Alex Delaney-Gesing
ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting.
Advertisement
ICYMI: Ramin Valian, vice president of International Glaucoma, Reimbursement and Pipeline at Allergan, discusses the takeaways from a panel discussion on the progression of glaucoma from a therapeutics/diagnostics and big data sets standpoint during the 2020 Glaucoma 360 meeting in San Francisco, California.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes
2
First patient dosed in phase 3 pivotal cohort of LIGHTHOUSE trial evaluating ATSN-201 for X-linked retinoschisis
3
NCX 470 gains positive regulatory feedback in China ahead of US NDA submission
4
Label Updates and Dosing Flexibility in Retinal Vascular Diseases
5























